Cameron IT

No ORCID on file · 7 papers in corpus · active 1991-2019

Study types

  • review 3
  • article 1
  • other 1

Condition tags

  • adenomyosis 4
  • endometriosis 2
2019
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd001016.pub3

BackgroundHeavy menstrual bleeding (HMB) is a menstrual blood loss perceived by women as excessive that affects the health of women of reproductive age, interfering with their physical, emotional, social and material quality of life. Whilst…

review 2017
British medical bulletin ·doi:10.1093/bmb/ldx027

Introduction: It is not uncommon for a woman to suffer from abnormal uterine bleeding (AUB) or heavy menstrual bleeding (HMB) at some point during her lifetime. Once pathology is excluded, in practice, management needs to be individualised,…

2013
Journal of immunology (Baltimore, Md. : 1950) ·doi:10.4049/jimmunol.1300958

Uterine NK cells (uNK) play a role in the regulation of placentation, but their functions in nonpregnant endometrium are not understood. We have previously reported suppression of endometrial bleeding and alteration of spiral artery morphol…

review 2003
Drugs of today (Barcelona, Spain : 1998) ·doi:10.1358/dot.2003.39.12.799415

The levonorgestrel intrauterine system is a safe, efficacious, long-term contraceptive device. Additionally, it results in a decrease in the volume of menstrual blood loss in women with normal periods and those with menorrhagia. It may also…

review 2001
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

The levonorgestrel intrauterine system (LNG-IUS) offers a new therapeutic concept that combines a highly efficient contraceptive with a treatment that reduces menstrual blood loss in both normal women and those with menorrhagia. Initially d…

other 2001
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.3109/ejc.6.s1.27.32

The levonorgestrel intrauterine system (LNG-IUS) offers a new therapeutic concept that combines a highly efficient contraceptive with a treatment that reduces menstrual blood loss in both normal women and those with menorrhagia. Initially d…

article 1991
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a137512

Endometrial proliferation is stimulated by oestradiol. The precise mechanism is poorly understood, but may be mediated by epidermal growth factor (EGF). The aim of the present study was to assess the effects of oestradiol and EGF on glandul…